Zymeworks Competitors and Similar CompaniesClear all

NovoCure's competitors and similar companies include Foghorn Therapeutics.

	NovoCure NovoCure is a company engaged in the development, manufacture, and commercialization of solutions for the treatment of solid tumors.	Foghorn Therapeutics Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.
Founding Date	Founding Date 2000	Founding Date 2016
Type	Type Public	Type Public
Tags	Tags Healthcare biotech medical devices oncology platform therapy	Tags Healthcare biotech oncology therapy
Locations	Locations Saint Helier, JE HQ München, DE Haifa, IL Tokyo, JP Root, CH Malvern, US New York, US see more	Locations Cambridge, US HQ Cambridge, US
Employees	Employees 1,488	Employees 1123% decrease
Valuation ($)	Valuation ($) 1.8 b	Valuation ($) 452 m
Financial
Revenue (est.)	Revenue (est.) $655.4m (FY, 2025)	Revenue (est.) $30.9m (FY, 2025)
Net income	Net income ($136.2m) (FY, 2025)	Net income ($74.4m) (FY, 2025)

For sources of this data, please see the company profile

Cambridge, US

Employees

112↓ 3% decrease

Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.

Financial